DAC HYP

New Data Presented at 64th AAN Annual Meeting Highlights Biogen Idec’s Commitment to Deliver Promising Therapies for Unmet Needs in Neurodegenerative Diseases
Yahoo/BusinessWire
Sat, 04/21/12 - 11:49 am
Biogen
Tysabri
Fampyra
BG-12
multiple sclerosis
amyotrophic lateral sclerosis
DAC HYP
Biogen and Abbott advance MS drug candidate
Bizjournals.com
Tue, 08/9/11 - 01:13 pm
DAC HYP
multiple sclerosis
MS
Abbott Laboratories
Biogen Idec
dalcizumab HYP